Actually, my point was that Dr. Paul was the "glue' that held the Janssen research team together. He had a knack for pointing his researchers in the right direction.
While it is true that a number of the compounds synthesized in his labs were potent cytochrome P-450 inhibitors leading to QT prolongation when taken with other drugs, there were a number of other compounds that were developed during his tenure that were not. Risperidone was one of them. J&J misses Paul Janssen.